top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Cancer Biomarkers and Targets in Digestive Organs / Nelson Yee, Nikki Lee
Cancer Biomarkers and Targets in Digestive Organs / Nelson Yee, Nikki Lee
Autore Yee Nelson
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (146 p.)
Soggetto topico Medicine
Soggetto non controllato liver graft injury
HFE
neurokinin
chemotherapy
intestinal tumors
therapeutic targets
biliary tract carcinoma
hepatocellular carcinoma
clinical trial
cell adhesion molecules
colorectal cancer
biomarkers
phenotypic mosaics
gastrointestinal oncology
Asian Cancer Research Group (ACRG)
biomarker
psychosocial support
precision therapy
pancreatic carcinoma
precision medicine
Liver transplantation
predictive biomarkers
CD274
cholecystokinin
The Cancer Genome Atlas (TCGA)
gastrin
pembrolizumab
immunotherapy
gastrin-releasing peptide
stereotactic body radiation therapy
immunohistochemistry
gastric carcinoma
liver transplant
CAM invasion assay
intragraft gene expression profiles
molecular profiling
targeted therapy
neurotensin
intestinal disorder
ramucirumab
next-generation sequencing
colorectal carcinoma
tumor progenitor
circulating tumor cells
gastrointestinal malignancies
bombesin
trastuzumab
somatostatin
zebrafish
G protein-coupled receptors
ISBN 9783039214648
3039214640
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367564003321
Yee Nelson  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunophenotyping in Autoimmune Diseases and Cancer
Immunophenotyping in Autoimmune Diseases and Cancer
Autore Szebeni Gábor J
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (170 p.)
Soggetto topico Medicine
Soggetto non controllato accidental cell death
Activating transcription factor 6 (ATF6)
B cells
breast cancer
cancer
cancer immunology
CD180
CD8+CD28− T cells
cell therapy
chimeric antigen receptor
choriocarcinoma
citrate synthase
CpG
dcSSc
DDR
DNA topoisomerase I
flow cytometry
galectin
galectin 1
gestational trophoblastic disease
glioblastoma
Glucose-regulated protein 78 (GRP78)
glycosylation
glycosylation enzymes
hydatidiform mole
IgM
IL-10
IL-6
immune cells
immunohistochemistry
immunophenotyping
immunotherapy
Inositol-requiring enzyme 1 (IRE1)
lectin binding
macrophage
malignant glioma
metastatic breast cancer
myeloid-derived suppressor cells
natural autoantibodies
neuroendocrine carcinoma
neuroendocrine neoplasia
neuroendocrine tumor
non-switched B cells
oncosis
parthanatos
PKR-like endoplasmic reticulum kinase (PERK)
placental-specific gene
RP105
sialylation
single cell mass cytometry
syntaxin 1
systemic lupus erythematosus
systemic sclerosis
systems biology
T cell
T cells
TLR
trastuzumab
trophoblast differentiation
tumor microenvironment
unfolded protein response
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557289203321
Szebeni Gábor J  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Pathways in Cancers
Molecular Pathways in Cancers
Autore Cristóbal Ion
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (284 p.)
Soggetto topico Medicine and Nursing
Oncology
Soggetto non controllato acetylation
actin cytoskeletal reorganization
adaptive immunity
advanced ovarian cancer
anti-receptor therapy
BET inhibitors
biomarkers
bladder cancer initiation
breast cancer
CALR
cancer
cancer immunology
cancer therapeutics
carcinogenicity
CD99 agonist
complement system
DUSP1
EGFR dimerization
endocytosis
epigenetic
epigenome
epithelial cells
FAK dephosphorylation
genome
glioblastoma
gp120
hepatocellular carcinoma
human immunodeficiency virus type 1
immune checkpoint inhibitors
immune evasion
immunotherapy
innate immunity
JAK2
luminal breast cancer
MAPK
matrix protein p17
metastasis
metastatic melanoma
methylation
migration and invasion
mitochondria
molecular targeted agents
MPL
MS-determined phosphopeptides
mTOR
myeloproliferative neoplasms
n/a
Nef
NIMA-related kinase 1 (NEK1)
non-coding RNA
OMD
oncogenic signaling pathway
ovarian cancer
oxidative stress
OXPHOS
pancreatic ductal adenocarcinoma
partial EMT
patient survival
pBRD4
PI3K
PP2A
PRELP
prognosis
prostate cancer
PTPN12
Rac1
reactive oxygen species
resistance
reverse transcriptase
RhoA
SET
signaling pathways
small-cell lung cancer
Snail
splicing pathway
TAK-228
Tat
thioridazine (THD)
tight junction
tousled-like kinase (TLK)
TPOR
trastuzumab
tripeptide
triple negative breast cancer
triple-negative breast cancer
tumor immune microenvironment
tumor microenvironment
tumor suppression gene
Warburg effect
yes-associated protein 1 (YAP1)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566473703321
Cristóbal Ion  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Treatment Strategies and Survival Outcomes in Breast Cancer
Treatment Strategies and Survival Outcomes in Breast Cancer
Autore Cheung Kwok-Leung
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (264 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato abemaciclib
advanced breast cancer
anthracycline resistance
antihormone therapy
APOBEC3B
aromatase inhibitors
ATM
basal-like breast cancer
biomarker
BRCA
breast cancer
Breast Cancer
breast cancer survivors
breast-conserving therapy
cancer treatment
cell-free DNA
CHEK2
chemotherapy
circulating tumor cells
cMet
colorectal cancer
comparative effectiveness
contralateral breast cancer
contralateral prophylactic mastectomy
cyclin E
disease-free survival
ductal carcinoma in situ
Endocrine therapy
ERCC1
exercise characteristics
family history
fulvestrant
gene expression
geriatric oncology
HDAC5 inhibitors
HER2 c-erbB2
HER2/neu
histone deacetylase
incidence
infiltrating breast cancer
invasive breast cancer
lactate dehydrogenase
lapatinib
LDH
liquid biopsy
LKB1
LMK-235
lymph-node ratio
mammography screening
mastectomy
metastatic
metastatic breast cancer
Metformin
monitoring metastatic breast cancer
mutation carriers
n/a
NCDB
next-generation sequencing
older patients
Older women
outcome
overdiagnosis
PALB2
palbociclib
pertuzumab
physical activity
physical function
PIK3CA
prognosis
radiotherapy
relative survival
ribociclib
SEER
serum biomarker
social well-being
Src kinase
stage IV
survival
T-DM1
taxane sensitivity
trastuzumab
tumor biology
young women
zero-inflated Poisson regression model
ISBN 3-03928-759-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910404084403321
Cheung Kwok-Leung  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui